TrialScientific reports2022

Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial.

Takashi Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.